Diagnosis of children with short stature: Insights from kigs

Growth Hormone Therapy in Pediatrics-20 Years of KIGS

Volumn , Issue , 2007, Pages 16-22

  Fujieda, Kenji ^a   Tanaka, Toshiaki ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77749295813     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000101495     Document Type: Chapter

References (5)

1. Ranke M, Lindberg A, Guilbaud O: Prediction of growth in response to treatment with growth hormone; in Ranke MB, Gunnarsson R (eds): Progress in Growth Hormone Therapy: 5 Years of KIGS. Mannheim, JJ Verlag, 1994, pp 97-111.
2. Ranke M: The KIGS aetiology classification system; in Ranke MB, Wilton P (eds): Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg, Johann Ambrosius Barth Verlag, 1999, pp 389-401.
3. Ellison JW, Wardak Z, Young MF, Gehron Robey P, Laig-Webster M, Chiong W: PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 1997; 6: 1341-1347.
4. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA: Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 1997; 16: 54-63.
5. Reiter EO: The demography of central nervous system neoplasms in growth hormone-treated patients found in the KIGS database. Pfizer International Growth Database Report No 22, Annual Report, 2004, pp 1-7.